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Dear Editor, 39 
 40 
Pituitary gigantism is caused by chronic growth hormone (GH) hypersecretion by a pituitary 41 
lesion before epiphyseal fusion. Genetic causes have been identified in nearly 50% of patients 42 
with pituitary gigantism, with germline mutations in the AIP gene being the most frequent cause 43 
(Rostomyan et al. 2015).  Recently, a new form of pituitary gigantism, X-linked acrogigantism 44 
(X-LAG), was described (Trivellin et al. 2014).  X-LAG is due to chromosome Xq26.3 45 
duplication and GPR101 is the disease-associated gene (Trivellin et al. 2014; Iacovazzo et al. 46 
2016). X-LAG is characterized by of mixed GH/prolactin-secreting pituitary macroadenomas 47 
and/or hyperplasia in early childhood (Beckers et al. 2015).  X-LAG typically occurs 48 
sporadically in females, but somatic mosaicism also occurs in males; familial mother-to-son 49 
transmission of the Xq26.3 duplication has been reported in three familial isolated pituitary 50 
adenoma families (Trivellin et al. 2014; Daly et al. 2016; Gordon et al. 2016; Iacovazzo et al. 51 
2016). The clinical presentation of X-LAG syndrome differs from other genetic forms of 52 
pituitary gigantism (Rostomyan et al. 2015) and many well-known historical cases of gigantism 53 
share the clinical characteristics of X-LAG syndrome (Beckers et al. 2015; Rostomyan et al. 54 
2015). If untreated during childhood X-LAG leads to established extreme gigantism (>1.9 55 
meters) before puberty (Daly et al. 2016). 56 
We studied a historical case of severe acro-gigantism.  The subject, J.K., was born in 1872 in 57 
Reutlingen, in what is now Baden-Württemberg, Germany.  His parents and brother were of 58 
normal size.  It was reported by his doctor that J.K. had always been “very large” and was 59 
reputed to have a huge appetite; he measured 1.94 meters at the age of 14 and never stopped 60 
growing thereafter (Launois & Roy 1904).  In contemporary Würtemberg the average adult 61 
male height was only 164 cm. By the 1890's he was exhibiting himself as Giant Constantine/Le 62 
Geant Constantin (Figure 1A).  In 1898 he was 259 cm in height (8 feet 6 inches) and weighted 63 
168 kilograms (370 pounds).  He fell ill while in the Walloon region of Belgium and was 64 
hospitalized on November 15, 1901, at the Hôpital Civil in Mons, Belgium with a fever (39.3ºC) 65 
due to severe lower limb gangrene.  Hospital records show his height as 256 cm and weight of 66 
180 kg.  He improved initially after an amputation of the right leg, but the following year he fell 67 
and the other leg was amputated below the knee.  He developed post-operative septicemia and 68 
died on March 30, 1902. At autopsy the pituitary was grossly enlarged to the size of “a large 69 
walnut” (Launois & Roy 1904).  The sella turcica was also greatly enlarged, so much so that it 70 
was remarked that “after removing the cerebral hemispheres and the cerebellum the sella was 71 
so broad and deep that it brought to mind two juxtaposed spinal canals” (Launois & Roy 1904) 72 
(Figure 1B, C).  The long bones and extremities were elongated and the proximal humeral 73 
epiphyses remained unfused (Launois & Roy 1904).  Concomitant hypogonadism (testicular 74 
atrophy) was present on examination and post-mortem.  Current forensic analysis of the 75 
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skeleton demonstrates bleaching of bones consistent with a reported preservation by prolonged 76 
boiling.   77 
Given the clinical history of early onset acrogigantism, an underlying genetic cause was thought 78 
to be likely.  DNA extraction from teeth was unreliable as the skull was edentulous when 79 
originally photographed in 1904 (Launois & Roy 1904); subsequently teeth were added to the 80 
skull but they could not be confirmed as coming from the subject himself.  The skeleton was 81 
fragile after preservation by prolonged boiling and DNA extraction from metatarsal and the 82 
femur were unsuccessful.  Based on results obtained from ancient skeletal remains, tissue from 83 
the cochlea was obtained via the petrous temporal bone (Pinhasi et al. 2015) as reported in 84 
Supplemental Materials. His history of early-onset, severe pituitary gigantism led us to suspect 85 
X-LAG (Trivellin et al. 2014; Daly et al. 2016). 86 
The DNA sample was assayed using a ddPCR technique as previously described (Daly et al. 87 
2016).  Briefly, the ddPCR compared copy number variations (CNV) at the GPR101 gene as 88 
compared with ZIC3, a gene that is not duplicated in X-LAG syndrome.  Daly et al recently 89 
showed this method was reliable for both confirming the results of known Xq26.3 duplication 90 
carriers and non-carriers, while also identifying duplication of GPR101 during screening of 91 
previously undiagnosed cases of X-LAG syndrome; the false positive rate in the acro-gigantism 92 
population was low (1/64 cases was borderline above the CNV minimal and maximal thresholds 93 
for duplication) (Daly et al. 2016).  The study was approved by the Natural History Museum of 94 
Mons and genetic studies regarding causes of gigantism and endocrine tumors was conducted 95 
under approval of the Ethics Committee of the Centre Hospitalier Universitaire de Liège, 96 
Belgium. 97 
We extracted DNA from cochlear core powder, then sequenced and post-processed it on a 98 
custom bioinformatics platform for ancient DNA.  The DNA had deamination patterns 99 
consistent with that of a nearly 100-year-old sample.  No pathological variants in AIP and other 100 
gigantism-associated genes (e.g. MEN1) were noted on obtained DNA read sequences. DNA 101 
was insufficient for array comparative genomic hybridization studies. The subject’s DNA 102 
exceeded the statistical thresholds for GPR101 duplication (copy number variation (CNV) value: 103 
3.49 vs. >2.0; Poisson CNV minimum value: 3.28 vs. >2.0), indicating X-LAG as a likely cause 104 
of his severe pituitary acrogigantism.  105 
The increased copy number for GPR101 strongly suggests that J.K. suffered from X-LAG 106 
syndrome.  The clinical and tumoral characteristics of X-LAG are supportive of this proposed 107 
diagnosis.  To achieve a height of 194 cm at the age of 14 in the 1870’s required a significant 108 
period of uninterrupted overgrowth. Apart from X-LAG, few other conditions are associated 109 
with early childhood-onset pituitary gigantism. The skeleton had no evidence of McCune-110 
Albright syndrome and AIP mutation-associated gigantism typically begins in mid-adolescence 111 
(Rostomyan et al. 2015). X-LAG syndrome is associated typically with mixed GH and prolactin 112 
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secreting pituitary adenomas (with variable hyperplasia); tumors are usually macroadenomas 113 
and can be large and invasive as in the subject’s case (Trivellin et al. 2014; Beckers et al. 2015).  114 
Testicular atrophy was also present in the current case that indicates significant effects of the 115 
pituitary tumor on gonadal function.  This would have kept the epiphyses thereby contributing 116 
to the final height of 259 cm. His proximal humeral epiphyses never fused, and his femoral 117 
epiphyses only fused late in his life, according to his autopsy accounts (Launois & Roy 1904).  118 
Hypogonadism could have been caused by tumor impingement upon gonadotropes, 119 
compounded by hyperprolactinemia which is common in X-LAG syndrome (Trivellin et al. 120 
2014; Beckers et al. 2015).  Few adult cases of X-LAG have been characterized, so the 121 
prevalence of hypogonadism due to tumor impingement is not known, but is a logical effect of a 122 
large tumor mass. 123 
Advances in sequencing technologies, DNA extraction methods, and bioinformatic analysis 124 
have allowed researchers to overcome challenges such as DNA authentication, contamination 125 
from modern and ancient sources, and have provided access to genetic material from samples 126 
thousands of years old and originating in tropical and desert environments (Pinhasi et al. 2015; 127 
Skoglund et al. 2016).  These extreme conditions are not optimal to the preservation of DNA. 128 
DNA has been retrieved from skeletal remains of other giants using techniques that have relied 129 
on DNA recovery from molar teeth.  In a recent historic gigantism case no AIP mutation was 130 
found; X-LAG was not studied but ddPCR specific to GPR101 and ZIC3 similar to that reported 131 
here could be informative (Radian et al. 2016).  As no DNA could be derived from teeth or 132 
other bony sites we utilized the novel approach of retrieving cochlear DNA from within the 133 
petrous temporal bone as developed and validated recently in population studies (Pinhasi et al. 134 
2015; Skoglund et al. 2016).  Even in skeletal samples that are preserved by suboptimal means 135 
during preservation, retrieval of DNA and strongly supportive information that is consistent 136 
with the patient’s clinical history can be obtained.  This approach could be applied more 137 
generally to other possible genetic disorders that are evident on skeletal remains.  Also, studies 138 
similar to this case could address the utility of other approaches to CNV analysis such as 139 
quantitative PCR on non-amplified genomic material.  The increasing number of ancient 140 
genomes that have been retrieved from phenotypically normal skeletons could provide a useful 141 
database of normal ancient DNA features and highlight the interference by environmental 142 
factors and age on the analysis and assessment of potentially disease-related variants.  143 
Valuable medical information can be gained from the genetic study of skeletal remains. While 144 
J.K. died before the era of pituitary tumor treatment, pituitary gigantism remains a difficult to 145 
treat condition today (Beckers et al. 2015; Rostomyan et al. 2015).  Better understanding of the 146 
natural disease history and potential genetic causes of historical giants should reinforce the need 147 
for early effective disease control. 148 
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